GlaxoSmithKline is buying a U.S. biotechnology company that is researching resveratrol, the chemical compound found in red wine that may retard the aging process. The CEO of the company says that “drugs that mimic resveratrol, by activating enzymes called sirtuins, could ‘treat in a safe, natural new way, many of the major killers of western society.'” We can’t wait to see the commercials that GSK puts out for this one.
Glaxo Buys Aging Retardation Drug Company
By cwalters April 24, 2008
- Partnering for health Google, GlaxoSmithKline Partner For $715M Bioelectronic Medicines Firm
- the price of getting well Senate Investigating Drug Companies Behind Huge Overnight Price Hikes
- even bigger pharma Pfizer To Buy Allergan For $160B, Create World’s Largest Drug Company
- the price of getting well Express Scripts To Offer $1 Version Of Drug That Skyrocketed To $750/Pill Overnight
- drug prices Cost Of Prescription Skin Gel Goes From $226 To $9,561 In Under Two Years